The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Antimicrobial, Antibiofilm, and Anti-persister Activities of Penfluridol Against Staphylococcus aureus
Abstract
Staphylococcus aureus has increasingly attracted global attention as a major opportunistic human pathogen owing to the emergence of biofilms (BFs) and persisters that are known to increase its antibiotic resistance. However, there are still no effective antimicrobial agents in clinical settings. This study investigated the antimicrobial activity of penfluridol (PF), a long-acting antipsychotic drug, against S. aureus and its clinical isolates via drug repurposing. PF exhibited strong bactericidal activity against S. aureus , with a minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of 4–8 and 16–32 μg/ml, respectively. PF could significantly inhibit biofilm formation and eradicate 24 h preformed biofilms of S. aureus in a dose-dependent manner. Furthermore, PF could effectively kill methicillin-resistant S. aureus (MRSA) persister cells and demonstrated considerable efficacy in a mouse model of subcutaneous abscess, skin wound infection, and acute peritonitis caused by MRSA. Notably, PF exerted almost no hemolysis activity on human erythrocytes, with limited cytotoxicity and low tendency to cause resistance. Additionally, PF induced bacterial membrane permeability and ATP release and further caused membrane disruption, which may be the underlying antibacterial mechanism of PF. In summary, our findings suggest that PF has the potential to serve as a novel antimicrobial agent against S. aureus biofilm- or persister-related infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These bacterial communities demonstrate high resistance to most antibacterial agents as well as to host defenses [9,15,16,17].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Persistent bacterial infections and persister cells
Fisher, R. A., Gollan, B., & Helaine, S. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.42 · Cited by 1,243
The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms
de Breij, A., Riool, M., Cordfunke, R. A., Malanovic, N., de Boer, L., Koning, R. I., Ravensbergen, E., Franken, M., van der Heijde, T., Boekema, B. K., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan4044 · Cited by 555
Fighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics
Defraine, V., Fauvart, M., & Michiels, J. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.03.002 · Cited by 222
Research works printed but not linked: 51
- Abraham, 2016, Going beyond the control of quorum-sensing to combat biofilm infections, Antibiotics, 5, 3, 10.3390/antibiotics5010003 · DOI
- Arciola, 2018, Implant infections: adhesion, biofilm formation and immune evasion, Nat. Rev. Microbiol., 16, 397, 10.1038/s41579-018-0019-y · DOI · Paper page
- Balant-Gorgia, 1987, Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring, Clin. Pharmacokinet., 13, 65, 10.2165/00003088-198713020-00001 · DOI
- Brynildsen, 2013, Potentiating antibacterial activity by predictably enhancing endogenous microbial ROS production, Nat. Biotechnol., 31, 160, 10.1038/nbt.2458 · DOI · Paper page
- Cuaron, 2013, Tea tree oil-induced transcriptional alterations in Staphylococcus aureus, Phytother. Res., 27, 390, 10.1002/ptr.4738 · DOI
- DelMain, 2020, Stochastic expression of sae-dependent virulence genes during Staphylococcus aureus biofilm development is dependent on SaeS, MBio, 11, e03081, 10.1128/mBio.03081-19 · DOI
- Dias, 2017, New potent membrane-targeting antibacterial peptides from viral capsid proteins, Front. Microbiol., 8, 775, 10.3389/fmicb.2017.00775 · DOI
- Domka, 2007, Temporal gene-expression in Escherichia coli K-12 biofilms, Environ. Microbiol., 9, 332, 10.1111/j.1462-2920.2006.01143.x · DOI · Paper page
- Elliott, 2020, An amphipathic peptide with antibiotic activity against multidrug-resistant gram-negative bacteria, Nat. Commun., 11, 3184, 10.1038/s41467-020-16950-x · DOI · Paper page
- Friedman, 2006, Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus, Antimicrob. Agents Chemother., 50, 2137, 10.1128/AAC.00039-06 · DOI · Paper page
- Gandra, 2020, Antimicrobial resistance surveillance in low- and middle-income countries: progress and challenges in eight south Asian and southeast Asian countries, Clin. Microbiol. Rev., 33, e00048, 10.1128/cmr.00048-19 · DOI · Paper page
- Garrison, 2015, Halogenated phenazines that potently eradicate biofilms, MRSA persister cells in non-biofilm cultures, and Mycobacterium tuberculosis, Angew. Chem. Int. Ed. Eng., 54, 14819, 10.1002/anie.201508155 · DOI
- Gerits, 2017, Repurposing toremifene for treatment of oral bacterial infections, Antimicrob. Agents Chemother., 61, e01846, 10.1128/aac.01846-16 · DOI
- Golan, 2019, Current treatment options for acute skin and skin-structure infections, Clin. Infect. Dis., 68, S206, 10.1093/cid/ciz004 · DOI
- Harbut, 2015, Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis, Proc. Natl. Acad. Sci. U. S. A., 112, 4453, 10.1073/pnas.1504022112 · DOI · Paper page
- Hassan, 2011, Evaluation of different detection methods of biofilm formation in the clinical isolates, Braz. J. Infect. Dis., 15, 305, 10.1016/S1413-8670(11)70197-0 · DOI · Paper page
- Joseph, 2016, Cationic pillararenes potently inhibit biofilm formation without affecting bacterial growth and viability, J. Am. Chem. Soc., 138, 754, 10.1021/jacs.5b11834 · DOI · Paper page
- Kaplan, 2011, Selective membrane disruption: mode of action of C16G2, a specifically targeted antimicrobial peptide, Antimicrob. Agents Chemother., 55, 3446, 10.1128/AAC.00342-11 · DOI · Paper page
- Kim, 2018, A new class of synthetic retinoid antibiotics effective against bacterial persisters, Nature, 556, 103, 10.1038/nature26157 · DOI · Paper page
- Kim, 2019, A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus, Proc. Natl. Acad. Sci. U. S. A., 116, 16529, 10.1073/pnas.1904700116 · DOI · Paper page
- Koo, 2017, Targeting microbial biofilms: current and prospective therapeutic strategies, Nat. Rev. Microbiol., 15, 740, 10.1038/nrmicro.2017.99 · DOI · Paper page
- Li, 2020, High-throughput identification of antibacterials against Pseudomonas aeruginosa, Front. Microbiol., 11, 591426, 10.3389/fmicb.2020.591426 · DOI
- Lima, 2021, In-depth characterization of antibacterial activity of melittin against Staphylococcus aureus and use in a model of non-surgical MRSA-infected skin wounds, Eur. J. Pharm. Sci., 156, 105592, 10.1016/j.ejps.2020.105592 · doi:10.1016/j.ejps.2020.105592
- Liu, 2020, Metformin restores tetracyclines susceptibility against multidrug resistant bacteria, Adv. Sci., 7, 1902227, 10.1002/advs.201902227 · DOI · Paper page
- Liu, 2015, Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains, Emerg. Microbes Infect., 4, e1, 10.1038/emi.2015.17 · doi:10.1038/emi.2015.17
- MacNair, 2018, Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics, Nat. Commun., 9, 458, 10.1038/s41467-018-02875-z · DOI · Paper page
- Miller, 2020, Development of a vaccine against Staphylococcus aureus invasive infections: evidence based on human immunity, genetics and bacterial evasion mechanisms, FEMS Microbiol. Rev., 44, 123, 10.1093/femsre/fuz030 · DOI · Paper page
- Miró-Canturri, 2020, Repositioning rafoxanide to treat gram-negative bacilli infections, J. Antimicrob. Chemother., 75, 1895, 10.1093/jac/dkaa103 · doi:10.1093/jac/dkaa103
- Mori, 2018, Structural basis of thalidomide enantiomer binding to cereblon, Sci. Rep., 8, 1294, 10.1038/s41598-018-19202-7 · DOI
- Nosengo, 2016, Can you teach old drugs new tricks?, Nature, 534, 314, 10.1038/534314a · DOI · Paper page
- Pletzer, 2018, Synergy between conventional antibiotics and anti-biofilm peptides in a murine, sub-cutaneous abscess model caused by recalcitrant ESKAPE pathogens, PLoS Pathog., 14, e1007084, 10.1371/journal.ppat.1007084 · DOI · Paper page
- Qu, 2020, A new coumarin compound DCH combats methicillin-resistant Staphylococcus aureus biofilm by targeting arginine repressor, Sci. Adv., 6, eaay9597, 10.1126/sciadv.aay9597 · DOI
- Ranjan, 2016, Penfluridol: an antipsychotic agent suppresses metastatic tumor growth in triple-negative breast cancer by inhibiting integrin signaling axis, Cancer Res., 76, 877, 10.1158/0008-5472.CAN-15-1233 · DOI
- Schein, 2020, Repurposing approved drugs on the pathway to novel therapies, Med. Res. Rev., 40, 586, 10.1002/med.21627 · DOI · Paper page
- She, 2020, Insights into idarubicin antimicrobial activity against methicillin-resistant Staphylococcus aureus, Virulence, 11, 636, 10.1080/21505594.2020.1770493 · DOI
- She, Efficacy of levofloxacin against biofilms of Pseudomonas aeruginosa isolated from patients with respiratory tract infections in vitro, Microbiology, 8, e00720, 10.1002/mbo3.720 · DOI
- She, Synergistic microbicidal effect of auranofin and antibiotics against planktonic and biofilm-encased S. aureus and E. faecalis, Front. Microbiol., 10, 2453, 10.3389/fmicb.2019.02453 · doi:10.3389/fmicb.2019.02453
- Smith, 2010, Influence of tigecycline on expression of virulence factors in biofilm-associated cells of methicillin-resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 54, 380, 10.1128/AAC.00155-09 · DOI
- Soares, 2006, Penfluridol for schizophrenia, Cochrane Database Syst. Rev., 2, Cd002923
- Song, 2020, A broad-spectrum antibiotic adjuvant reverses multidrug-resistant gram-negative pathogens, Nat. Microbiol., 5, 1040, 10.1038/s41564-020-0723-z · DOI · Paper page
- Su, 2019, Evaluation of platensimycin and platensimycin-inspired thioether analogues against methicillin-resistant Staphylococcus aureus in topical and systemic infection mouse models, Mol. Pharm., 16, 3065, 10.1021/acs.molpharmaceut.9b00293 · DOI
- Tan, 2019, Bactericidal and anti-biofilm activity of the retinoid compound CD437 against Enterococcus faecalis, Front. Microbiol., 10, 2301, 10.3389/fmicb.2019.02301 · DOI
- Thakare, 2017, Repurposing Ivacaftor for treatment of Staphylococcus aureus infections, Int. J. Antimicrob. Agents, 50, 389, 10.1016/j.ijantimicag.2017.03.020 · doi:10.1016/j.ijantimicag.2017.03.020
- Thangamani, 2016, Repurposing auranofin for the treatment of cutaneous staphylococcal infections, Int. J. Antimicrob. Agents, 47, 195, 10.1016/j.ijantimicag.2015.12.016 · DOI
- Tuan, 2019, Penfluridol as a candidate of drug repurposing for anticancer agent, Molecules, 24, 3659, 10.3390/molecules24203659 · DOI
- Turner, 2019, Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research, Nat. Rev. Microbiol., 17, 203, 10.1038/s41579-018-0147-4 · DOI · Paper page
- van Dalen, 2020, Wall teichoic acid in Staphylococcus aureus host interaction, Trends Microbiol., 28, 985, 10.1016/j.tim.2020.05.017 · DOI
- Wilson, 2021, Transport of lipopolysaccharides and phospholipids to the outer membrane, Curr. Opin. Microbiol., 60, 51, 10.1016/j.mib.2021.01.006 · DOI
- Yasir, 2019, Mechanism of action of surface immobilized antimicrobial peptides against Pseudomonas aeruginosa, Front. Microbiol., 10, 3053, 10.3389/fmicb.2019.03053 · DOI
- Zeng, 2021, Drug repurposing: antimicrobial and antibiofilm effects of penfluridol against Enterococcus faecalis, Microbiology, 10, e1148, 10.1002/mbo3.1148 · DOI
- Zhou, 2020, Repurposing antispasmodic agent otilonium bromide for treatment of Staphylococcus aureus infections, Front. Microbiol., 11, 1720, 10.3389/fmicb.2020.01720 · DOI
Cited by
Verdial, C., Serrano, I., Tavares, L., Gil, S., & Oliveira, M. (2023) · Biomedicines · doi:10.3390/biomedicines11041221 · Cited by 71
Population-based high-throughput toxicity screen of human iPSC-derived cardiomyocytes and neurons
Huang, C. Y., Nicholson, M. W., Wang, J. Y., Ting, C. Y., Tsai, M. H., Cheng, Y. C., Liu, C. L., Chan, D. Z. H., Lee, Y. C., Hsu, C. C., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110643 · Cited by 36
Self-citationSerrano, I., Alhinho, B., Cunha, E., Tavares, L., Trindade, A., & Oliveira, M. (2023) · Life · doi:10.3390/life13020504 · Cited by 33
Metadata
- Authors
- Liu, Y., She, P., Xu, L., Chen, L., Li, Y., Liu, S., Li, Z., Hussain, Z., & Wu, Y.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2021-08-18
- Volume
- 12
- ISSN
- 1664-302X
- Cited by
- 51
- References
- 3
- Funders
- National Natural Science Foundation of China (82072350)
- Natural Science Foundation of Hunan Province (2019JJ80029)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antimicrobial, Antibiofilm, and Anti-persister Activities of Penfluridol Against Staphylococcus aureus. https://app.cochat.ai/papers/10.3389/fmicb.2021.727692
- The paper
- Liu, Y., She, P., Xu, L., Chen, L., Li, Y., Liu, S., Li, Z., Hussain, Z., & Wu, Y. (2021). Antimicrobial, Antibiofilm, and Anti-persister Activities of Penfluridol Against Staphylococcus aureus. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2021.727692
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.